Tus kws kho mob
P30-23 Gender Affirming Care
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2023
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1471 - 1480 ntawm 3685
Tus kws kho mob
P34-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2023
Tus kws kho mob
P35-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2023
Tus kws kho mob
2023 May Bulletins
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 01, 2023
Tus kws kho mob
QP39-23 Commercial Pharmacy Benefit Exclusion for Lamzede®
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 10, 2023
Tus kws kho mob
QP40-23 MHCP Pharmacy Benefit Exclusion for Lamzede® and Zynyz™
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 10, 2023
Tus kws kho mob
QP41-23 Makena® (hydroxyprogesterone caproate): Drug Approval Withdrawn
Hnub Tim pib siv tau lub khoos kas: Lub Tsib Hlis Ntuj Tim 10, 2023
Cov Txiaj Ntsig thiab Kev Duav Roos
MinnesotaCare 2023 Spanish Member Handbook
Cov Txiaj Ntsig thiab Kev Duav Roos
Blue Advantage Families & Children 2023 Spanish Member Handbook
Tus kws kho mob
bc-mhcp-pharmprogpolicynotifctn-final-eff-5.1.23.pdf